Dr. Francisco Arredondo Opens First U.S. INVOcell Center in McAllen, Texas
ACCESSWIRE ACCESSWIRESeptember 6, 2017Comment
MCALLEN, TX and MEDFORD, MA / ACCESSWIRE / September 6, 2017 / INVO Bioscience, Inc. (OTC PINK: IVOB), a medical device company who was granted FDA clearance for the first Intravaginal Culture System, INVOcell™, today announced the opening of the United States' first fertility center to exclusively offer the INVOcell device and solution to patients. The INVOcell center is an extension of RMA of Texas, a leading provider of fertility-based solutions with multiple locations in Texas. The INVOcell center, based in McAllen, Texas, is under the direction of Dr. Francisco Arredondo, MD, a respected and experienced board certified reproductive endocrinologist who has published numerous papers on infertility.
Dr. Francisco Arredondo opens first U.S. INVOcell Center in McAllen, Texas
Branded by Dr. Arredondo as Smart IVF, the center will offer INVOcell's patented medical device that enables egg fertilization and early embryo development to take place in the woman's body, in vivo. By utilizing the women's own body as an incubator, it decreases the number of office visits, blood work, monitoring and other costs associated with traditional in vitro fertilization (IVF). These decreased input costs translate into an approximate 50% reduction in the overall cost per cycle for patients. Despite the decreased costs, pregnancy rates with INVOcell are equivalent to that of traditional IVF.
Francisco Arredondo, MD MPH, founder of Smart IVF, a subsidiary of RMA of Texas, commented, "INVOcell is a true breakthrough for infertility treatment. I began offering the INVOcell solution to patients at my fertility clinics in San Antonio and Austin in April 2016. Due to the success we had in expanding the accessibility of infertility treatment to patients, we decided to open a center where we would exclusively offer the INVOcell solution. Since our pre-launch in April 2017, we have now treated 68 patients in our new McAllen location. I am excited about the opportunity afforded to us by INVOcell to bring an effective and affordable fertility treatment option to Southern Texas."
"Dr. Arredondo has been an early champion of the INVOcell solution," said Katie Karloff, Chair and Chief Executive Officer of INVO Bioscience. "The successful launch of a clinic exclusively offering INVOcell in McAllen, Texas, a location void of traditional IVF centers, validates a number of assumptions we have about the opportunity to expand accessibility to fertility treatment. We look forward to working with Dr. Arredondo and other physicians around the United States to bring INVOcell centers to large metropolitan areas, as well as smaller remote locations, where traditional IVF centers would be financially unfeasible."
